0001437749-22-022646.txt : 20220916 0001437749-22-022646.hdr.sgml : 20220916 20220916182437 ACCESSION NUMBER: 0001437749-22-022646 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220914 FILED AS OF DATE: 20220916 DATE AS OF CHANGE: 20220916 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kunin Audrey CENTRAL INDEX KEY: 0001738781 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33678 FILM NUMBER: 221249038 MAIL ADDRESS: STREET 1: 4346 BELGIUM BLVD NW CITY: RIVERSIDE STATE: MO ZIP: 64150 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NovaBay Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001389545 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 680454536 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2000 POWELL STREET, SUITE 1150 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: (510) 899-8800 MAIL ADDRESS: STREET 1: 2000 POWELL STREET, SUITE 1150 CITY: EMERYVILLE STATE: CA ZIP: 94608 4 1 rdgdoc.xml FORM 4 X0306 4 2022-09-14 0001389545 NovaBay Pharmaceuticals, Inc. NBY 0001738781 Kunin Audrey C/O NOVABAY PHARMACEUTICALS, INC. 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 1 1 Chief Product Officer Common Stock 2022-09-14 4 S 0 291368 0.1582 D 208632 I See footnote This transaction was executed in multiple trades at prices ranging from $0.1565 to $0.1605. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. By The Audrey G. Kunin Trust in which the reporting person serves as the trustee and has investment control. /s/ Audrey Kunin 2022-09-16